Jazz Pharmaceuticals plc (JAZZ)
ROA
Obliczenia
|
2022/Q4 (31 gru 2022) |
2022/Q3 (30 wrz 2022) |
2022/Q2 (30 cze 2022) |
2022/Q1 (31 mar 2022) |
2021/Q4 (31 gru 2021) |
2021/Q3 (30 wrz 2021) |
2021/Q2 (30 cze 2021) |
2021/Q1 (31 mar 2021) |
||
|---|---|---|---|---|---|---|---|---|---|
| Zysk netto (ttm) | w tys. USD | -224 060 | -18 687 | -51 872 | -449 853 | -329 668 | -160 903 | 40 164 | 518 281 |
| Aktywa razem | w tys. USD | 10 835 300 | 10 384 700 | 11 200 100 | 11 768 900 | 12 298 600 | 12 478 200 | 13 213 000 | 6 756 470 |
| ROA | -2,07% | -0,18% | -0,46% | -3,82% | -2,68% | -1,29% | 0,30% | 7,67% |
2022/Q4 obliczenia
ROA = Zysk netto (ttm) ÷ Aktywa razem
= $-224 060K ÷ $10 835 300K
= -2,07%
Analiza porównawcza
2022/Q4
Nazwa spółki
Symbol
ROA
Jazz Pharmaceuticals plc
JAZZ
-2,07%
Arrowhead Pharmaceuticals Inc.
ARWR
-17,33%
Catalent Inc.
CTLT
3,65%
Cytokinetics Inc
CYTK
-38,33%
Harmony Biosciences Holdings Inc
HRMY
26,93%
Organon & Co.
OGN
9,69%
Perrigo Company plc
PRGO
-1,28%
Prestige Consumer Healthcare Inc
PBH
5,61%
Supernus Pharmaceuticals Inc
SUPN
2,22%
United Therapeutics Corp
UTHR
12,03%
Viatris Inc
VTRS
4,16%